Expected investment changes in biopharma and diagnostic lab services 2021

Published by
Matej Mikulic,
Jun 1, 2021
For 2021, 25 percent of surveyed U.S. investment professionals stated that they expect investment in the area of diagnostic lab services to increase by more than 20 percent. This statistic illustrates the expected investment changes in biopharma services and diagnostic lab services in 2021, by subsector.

Expected investment changes in biopharma and diagnostic lab services in 2021, by subsector

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2021

Region

United States

Survey time period

November 19, 2020, to December 30, 2020

Number of respondents

286 respondents

Special properties

U.S. healthcare and life sciences investment professionals

Method of interview

Online survey

Supplementary notes

Percentage points missing/exceeding 100 percent are probably due to rounding.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharma and biotech M&A activity "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharma and biotech M&A activity

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical and biotech M&A activitiesGlobal pharmaceutical industryM&As worldwideM&As in EuropeM&As in the United States
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.